The NGen supercluster has awarded $27 million in funding for 12 advanced manufacturing projects that can supply critical health care products to combat COVID-19. The funding includes $5 million for Providence Therapeutics and partner Northern RNA to establish manufacturing capacity in Calgary for Providence’s made-in-Canada vaccine.
Person: Jayson Myers
A R$ webinar with the CEOs of Canada’s five innovation superclusters reported on the impact of COVID-19
Strong industry leadership without burdensome government bureaucracy will be key to Canada’s superclusters’ success, R$ conference hears.
Small Canadian manufacturing companies and technology firms will reap big benefits from the new Advanced Manufacturing Supercluster, says the chief executive leading the initiative.